FDA clears Spectranetics laser support catheter
Spectranetics has obtained FDA clearance for its Cross-Pilot laser support catheter.
The Colorado Springs, Colo.-based company said its Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The braid-reinforced catheter construction and hydrophilic coating allow for better maneuvering through distal vessels and the angled tip allows for quicker access to branched anatomy.
Spectranetics said it will launch the product during the first quarter of 2009 within the U.S., Europe and Canada. The Cross-Pilot is currently offered in 125 cm length, and straight and angled tip configurations.
The Colorado Springs, Colo.-based company said its Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The braid-reinforced catheter construction and hydrophilic coating allow for better maneuvering through distal vessels and the angled tip allows for quicker access to branched anatomy.
Spectranetics said it will launch the product during the first quarter of 2009 within the U.S., Europe and Canada. The Cross-Pilot is currently offered in 125 cm length, and straight and angled tip configurations.